You are on page 1of 1

Consensus Statement on Anesthetic

Management of Pregnant and Postpartum


Women Receiving Thromboprophylaxis
or Higher Dose Anticoagulants
Unfractionated Heparin
Intrapartum Postpartum
Subcutaneous Elective Class Urgent and Emergent Class Recommendation Class

Wait a minimum of 4-6h In circumstances Regardless of dose,


or consider assessing involving select high-risk lla wait ≥1h after neuraxial
coagulation status lla
parturients receiving C-EO placement or catheter
before neuraxial C-EO
venous thromboembolism removal before next dose
Low dose prophylaxis and requiring of UFH
Ex. 5000 U SQ BID or TID
urgent interventions for
maternal or fetal
Wait a minimum of 12h indications, the risk of
llb
and assess coagulation general anesthesia may Indwelling catheters can
lla lla C-EO
status before neuraxial be greater than neuraxial be maintained on UFH
C-EO anesthesia, and C-EO 5000 U SQ BID or TID
Intermediate dose
Ex. 7500-10,000 U SQ BID exceptions or (catheter removal ≥4-6h
modifications of the after last dose and
guidelines may be subsequent dose ≥1h
Wait a minimum of 24h appropriate. after removal)
and assess coagulation lla llb
status before neuraxial C-EO C-EO
High dose
Ex. >10,000 U SQ per dose or
>20,000 U SQ total daily dose

Intravenous Elective Class Urgent and Emergent Class Recommendation Class

Wait a minimum of 4-6h Wait ≥1h after neuraxial llb


and assess coagulation lla placement before initiating C-EO
status before neuraxial C-EO or restarting UFH

Low Molecular Weight Heparin


Intrapartum Postpartum
Subcutaneous Elective Class Urgent and Emergent Class Recommendation Class

Wait a minimum of In circumstances Wait a minimum of 12h


12h before neuraxial involving select high-risk after neuraxial placement
parturients receiving and a minimum of 4h after
venous thromboembolism catheter removal before
Low dose prophylaxis and requiring next dose of LMWH
Ex. Enoxaparin ≤40 mg I llb I
SQ daily or ≤30 mg SQ BID C-EO urgent interventions for C-EO C-EO
Indwelling catheters can be
maternal or fetal
maintained on low dose
indications, the risk of
LMWH (catheter removal ≥
general anesthesia may
12h after last dose and
be greater than neuraxial
subsequent dose ≥4h after
anesthesia, and
removal)
exceptions or
modifications of the
Wait a minimum of 24h guidelines may be
Wait a minimum of 24h
before neuraxial appropriate.
after neuraxial placement
(insufficient data to and a minimum of 4h
llb llb
recommend shortening
Intermediate dose C-EO C-EO after catheter removal
interval compared to
Ex. Enoxaparin >40 mg SQ before initiating or restarting
daily or >30 mg SQ BID high dose)
LMWH I
AND <1 mg/kg SQ BID or
1.5 mg/kg SQ daily C-EO

Wait a minimum of
24h before neuraxial I llb
C-EO C-EO
High dose
Ex. Enoxaparin ≥1 mg/kg
SQ BID or ≥1.5 mg/kg SQ daily

UFH - unfractionated heparin; LMWH - low molecular weight heparin; SQ - subcutaneous; BID - twice daily;
TID - three times daily; U - units

*Class (strength of recommendation) and level (quality of evidence) of each recommendation based on
American Heart Association grading scale. All recommendations assume normal renal function, body weight
> 40 kg, and no other contraindications to neuraxial anesthesia.

This is not to be interpreted as medical advice, and every patient circumstance must be individualized.
This infographic represents a summary of the
recommendations in the "Consensus Statement
on the Anesthetic Management of Pregnant and
Postpartum Women Receiving Thromboprophylaxis
or Higher Dose Anticoagulants". Please reference
the full consensus statement for further information.

You might also like